Reference is made to the previous announcements regarding the merger between
Aker BioMarine ASA (the "Aker BioMarine") and Aker Capital NewCo AS
("MergerCo"), an indirect wholly-owned subsidiary of Aker ASA ("Aker").
As announced on 30 September 2026, all conditions for completion of the merger
are satisfied. Today, 1 October 2026, the Merger was registered in the Norwegian
Register of Business Enterprises.
Shareholders in Aker BioMarine (other than MergerCo) will for each Aker
BioMarine share held as of the expiry of 1 October 2026 (as registered in
Euronext Securities Oslo (VPS) on 5 October 2026 (the record date)) receive
merger consideration in the form of 0.0706 shares in Aker, plus a cash amount of
NOK 21 per share.
Fractions of Aker consideration shares will not be allotted in the Merger. For
each Aker BioMarine shareholder the number of Aker shares will be rounded down
to each whole number, or to zero shares. Excess shares, which because of this
round down will not be allotted to eligible shareholders, will be issued to and
sold by an appointed investment bank or other third party according to
instructions from Aker at the expense and risk of the beneficiaries, with a
proportionate distribution of net sales proceeds among the shareholders who have
the number of consideration shares rounded off.
The consideration shares are expected to be delivered to, and the cash
consideration is expected to be paid to, the former Aker BioMarine shareholders
(other than MergerCo) on 6 October 2026 and 7 October 2026, respectively.
26 and 7 October 2026\, respectively. \